Proteolytic enzymes in the zymogen form to treat sarcoma cells

Details Proteolytic enzymes in the zymogen form to treat sarcoma cells Proteolytic enzymes in the zymogen form to treat sarcoma cells

1983-07-27

1985-04-30

Rosen, Sam

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

A61K 3754, A61K 37547

Patent

active

045143889

ABSTRACT:
A method and composition is disclosed for the prophylactic treatment of cancer tumor cells contained in a host body having a natural immunological system and wherein the tumor cells have a protective surface resistant to the immunological system, to prevent or at least reduce further development of the tumor cells comprising; introducing a solution of a proenzyme and a pharmaceutically acceptable carrier into the host body adjacent the tumor cells, the solution having a concentration of the proenzyme at least in excess of the proenzymes produced by the host body in the area of the tumor cells, and contacting the tumor cells with the proenzyme whereby the proenzyme is converted to its active form which reacts with the tumor cell surface to sufficiently decompose the surface to permit the natural immunological system to prevent or reduce development of tumor cells.

REFERENCES:
Chem. Abst., 10th Coll., Chem. Subst. Index, vol. 86-95, (1977-1981) p. 54094cs.
Oliveira et al-Chem. Abst., vol. 93, (1980), p. 1490s.

Affiliated with

Also associated with

Rating

Proteolytic enzymes in the zymogen form to treat sarcoma cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Proteolytic enzymes in the zymogen form to treat sarcoma cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteolytic enzymes in the zymogen form to treat sarcoma cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1967818